Related Experiment Video
Updated: Jul 8, 2026
Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
CLL cell apoptosis induced by nitric oxide synthase inhibitors: correlation with lipid solubility and NOS1
Marc C Levesque1, Dipak K Ghosh, Bethany E Beasley
1Department of Medicine, Division of Rheumatology and Clinical Immunology, Duke University and Durham VA Medical Centers, Durham, NC 27710, United States. marc.levesque@duke.edu
Abstract:
Nitric oxide synthase (NOS) inhibitors induce chronic lymphocytic leukemia (CLL) cell apoptosis and have potential as CLL therapeutics. We determined the half-maximal concentration (ED(50)) of 22 NOS inhibitors that induced CLL cell death in vitro. There was a direct correlation of the NOS1 (but not NOS2) dissociation constant (K(d)) and the hydrophobicity partitioning coefficient of each NOS inhibitor and its ED(50). NOS inhibitors that bound tightly to CLL cell NOS1 and were hydrophobic potently induced CLL cell death. CLL cell RNA and protein analyses confirmed CLL cell NOS1 expression. Our studies permit the rational selection of NOS inhibitors for testing as CLL therapeutics.
Insights
Nitric oxide synthase (NOS) inhibitors can kill chronic lymphocytic leukemia (CLL) cells. Hydrophobic NOS inhibitors binding tightly to NOS1 show the most potent cancer cell death, aiding therapeutic selection.
Area of Science:
- Biochemistry
- Oncology
- Pharmacology
Background:
- Chronic lymphocytic leukemia (CLL) is a B-cell malignancy.
- Nitric oxide synthase (NOS) inhibitors show promise in inducing apoptosis in cancer cells.
- Targeting NOS pathways represents a potential therapeutic strategy for CLL.
Purpose of the Study:
- To evaluate the efficacy of various NOS inhibitors in inducing CLL cell death.
- To identify the characteristics of NOS inhibitors that correlate with potent CLL cell apoptosis.
- To establish a basis for rational selection of NOS inhibitors for CLL treatment.
Main Methods:
- In vitro assessment of 22 NOS inhibitors for their ability to induce CLL cell death.
- Determination of half-maximal effective concentration (ED50) for each inhibitor.
- Correlation analysis of inhibitor properties (dissociation constant Kd, hydrophobicity) with their ED50 values.
- Confirmation of NOS1 expression in CLL cells via RNA and protein analysis.
Main Results:
- A direct correlation was observed between the NOS1 dissociation constant (Kd) and hydrophobicity of NOS inhibitors and their ED50 values.
- NOS inhibitors with high affinity for NOS1 and increased hydrophobicity demonstrated potent induction of CLL cell death.
- NOS1 expression was confirmed in CLL cells at both RNA and protein levels.
- No significant correlation was found between NOS2 binding and inhibitor efficacy.
Conclusions:
- NOS1 is expressed in CLL cells and is a viable therapeutic target.
- Hydrophobicity and tight binding to NOS1 are key characteristics for potent NOS inhibitor efficacy in CLL.
- These findings support the rational design and selection of NOS inhibitors for clinical testing in CLL therapeutics.
